awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51637913-B5DDA467-153F-4EA0-96E7-F261B269188D
Q51637913-B5DDA467-153F-4EA0-96E7-F261B269188D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51637913-B5DDA467-153F-4EA0-96E7-F261B269188D
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.
P2860
Q51637913-B5DDA467-153F-4EA0-96E7-F261B269188D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51637913-B5DDA467-153F-4EA0-96E7-F261B269188D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cb02610da4f337d4f1adddc179398d5fac26825c
P2860
Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis.